Philips buys ADAC to exploit high growth PET market
This article was originally published in Clinica
Executive Summary
Philips Medical Systems is to expand its imaging range with the $426 million acquisition of ADAC Laboratories, the nuclear medicine and radiation therapy systems company. Philips will pay $18.50 per share for each outstanding ADAC share. The deal represents a premium on ADAC's closing price of $18.13.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.